Pigmented Nodular Adrenocortical Disease, Primary, 2
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
3
|
5
|
0.600 |
strong |
1.000 |
1 |
5
|
2006 |
2006 |
Primary pigmented nodular adrenocortical disease
|
disease |
|
Disease or Syndrome
|
22
|
1
|
0.320 |
None |
1.000 |
3 |
|
2006 |
2019 |
Major Depressive Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1236
|
1451
|
0.310 |
None |
1.000 |
1 |
|
2006 |
2006 |
Unipolar Depression
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
641
|
225
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Adrenal hyperplasia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Endocrine System Diseases
|
Disease or Syndrome
|
33
|
|
0.120 |
None |
1.000 |
2 |
|
2009 |
2010 |
Congenital adrenal hyperplasia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
87
|
36
|
0.120 |
None |
1.000 |
2 |
|
2009 |
2010 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
2 |
3
|
2010 |
2019 |
Systolic Pressure
|
phenotype |
|
Clinical Attribute
|
843
|
1931
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Height
|
phenotype |
|
Organism Attribute
|
249
|
517
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Myopia
|
disease |
Eye Diseases
|
Disease or Syndrome
|
490
|
167
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Diastolic blood pressure
|
phenotype |
|
Clinical Attribute
|
507
|
1037
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
heart rate
|
phenotype |
|
Clinical Attribute
|
36
|
103
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
2096
|
1536
|
0.100 |
None |
1.000 |
1 |
2
|
2010 |
2010 |
response to ACE inhibitor
|
phenotype |
|
Organism Function
|
15
|
26
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Pigmented micronodular adrenocortical disease
|
phenotype |
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
Short stature
|
phenotype |
|
Finding
|
1127
|
292
|
0.100 |
None |
|
0 |
|
|
|
Round face
|
phenotype |
|
Finding
|
88
|
3
|
0.100 |
None |
|
0 |
|
|
|
Paradoxical increased cortisol secretion on dexamethasone suppression test
|
phenotype |
|
Finding
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Mental deterioration
|
phenotype |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
508
|
121
|
0.100 |
None |
|
0 |
|
|
|
Linear atrophy
|
disease |
Pathological Conditions, Signs and Symptoms
|
Acquired Abnormality
|
149
|
6
|
0.100 |
None |
|
0 |
|
|
|
Muscle Weakness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases; Nervous System Diseases
|
Sign or Symptom
|
536
|
87
|
0.100 |
None |
|
0 |
|
|
|
Agitation, CTCAE 5.0
|
phenotype |
|
Finding
|
87
|
|
0.100 |
None |
|
0 |
|
|
|
Thin skin
|
phenotype |
|
Finding
|
77
|
4
|
0.100 |
None |
|
0 |
|
|
|
Increased tendency to bruise
|
phenotype |
Wounds and Injuries
|
Finding
|
133
|
14
|
0.100 |
None |
|
0 |
|
|
|
Truncal obesity
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Finding
|
38
|
4
|
0.100 |
None |
|
0 |
|
|
|